Adam M Burgoyne Selected Research

Adam M Burgoyne Research Topics

13	Neoplasms (Cancer) 01/2022 - 09/2009
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2016
2	Glioblastoma (Glioblastoma Multiforme) 04/2010 - 09/2009
2	Astrocytoma (Pilocytic Astrocytoma) 04/2010 - 12/2009
1	Inflammation (Inflammations) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Necrosis 12/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021
1	Carcinogenesis 01/2019
1	Glioma (Gliomas) 12/2009

4	Pharmaceutical PreparationsIBA 01/2022 - 09/2009
3	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 01/2018
3	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 04/2010 - 09/2009
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2022 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 11/2016
2	Peptides (Polypeptides)IBA 04/2010 - 09/2009
2	Protein Tyrosine PhosphatasesIBA 04/2010 - 09/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	atezolizumabIBA 01/2022
1	O-methyl-serine dodecylamide hydrochlorideIBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	NivolumabIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 12/2021
1	platelet-derived growth factor C (PDGF-C)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2020
1	Succinic Acid (Succinate)IBA 01/2019
1	Biological ProductsIBA 12/2016
1	SF 1126IBA 11/2016
1	sperm releasing substanceIBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	Small Interfering RNA (siRNA)IBA 09/2009